← Leaderboards
Mathew J Ewend
University Of North Carolina Chapel Hill
$0
Attributed
$0
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$0 · 2
By mechanism
M01$0 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Andrew L Lee$10,585,321
- Charles Michael Van Der Horst$17,688,631
- John B Buse$71,388,050
- Aziz Sancar$33,098,063
- Kuo-Hsiung Lee$16,683,783
Others in their field
Top investigators on “Quality Of Life”
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Gregory H Reaman · National Childhood Cancer Foundation$264,644,476
- David R. Weir · University Of Michigan At Ann Arbor$263,050,576
- Richard K. Wilson · Washington University$198,912,538
Research focus
Quality Of LifeClinical ResearchDrug Administration Rate /DurationDrug Adverse EffectDrug Screening /EvaluationGlioblastoma MultiformeHuman SubjectHuman Therapy EvaluationIntravenous AdministrationNeoplasm /Cancer ChemotherapyNeoplasm /Cancer Relapse /RecurrenceAntineoplasticsProcarbazineOral Administration
Grant awards (5)
SU101 VS PROCARBAZINE FOR GLIOBLASTOMA MULTIFORME PTS$0
M01 · FY2000 · RR
SU101 FOR PTS W/ ANAPLASTIC ASTROCYTOMA IN FIRST RELAPSE$0
M01 · FY2000 · RR
SU101 FOR PTS W/ ANAPLASTIC ASTROCYTOMA IN FIRST RELAPSE$0
M01 · FY2000 · RR
SU101 FOR PTS W/ ANAPLASTIC ASTROCYTOMA IN FIRST RELAPSE$0
M01 · FY2000 · RR
SU101 FOR PTS W/ ANAPLASTIC ASTROCYTOMA IN FIRST RELAPSE$0
M01 · FY2000 · RR